Working with physician groups and exposing them to the extent and risks of off-label, providing easy to access information on the product monograph so they could identify off-label prescribing, supporting or facilitating a process for off-label prescribing is probably where I would start.

This is not without risk. Risk can be considerably mitigated by Health Canada through a systematic and deliberate monitoring of the effects of all drugs in use in the general population and by informing physicians and patients of the latest risks and benefits of the use of pharmaceuticals, especially those used off-label.

(Return tabled) Question No. 845 Ms. Kirsty Duncan: With regard to children’s health and the environment: (a) what action has the government undertaken to integrate children’s environmental health into existing public health programs; (b) what specific action is the government undertaking to advocate for the consideration and assessment of hazardous environmental influences on children’s health and development, (i) in Canada, (ii) internationally; (c) what specific action is the government undertaking to raise the political profile of children’s environmental health, (i) locally, (ii) regionally, (iii) nationally; (d) in relation to its contaminated sites, (i) what specific action is the government undertaking to raise awareness about ch ...[+++]ildren’s environmental health, (ii) what are all contaminated sites where action has been taken to raise awareness, (iii) what was the risk; (iv) what was the action taken; (e) what are all government activities focused on children’s environmental health; (f) what are all existing government activities focused on prevention of environmental exposures aimed at protecting children's health; (g) what governmental action has been undertaken to prevent (i) pre-conception, prenatal, and childhood exposures, (ii) air, consumer products, food, soil/dust, water, and other physical environmental exposures, (iii) biological, chemical, and physical hazards; (h) how has the government taken children's vulnerabilities into account in developing environmental and health policies, regulations, and standards; (i) what targeted environmental and health policies, regulations, and standards have already been put in place to protect children's health, and what policies, regulations, and standards are currently under consideration; (j) what action is being undertaken by the government to measure the extent to which pregnant women and their babies are exposed to common environmental chemicals, and what health risks, if any, are associated with th ...

(d) Plastic parts heavier than 25 grams shall not contain flame retardant substances or preparations containing substances that are or may be assigned any of the risk phrases R45 (may cause cancer), R46 (may cause heritable genetic damage), R50 (very toxic to aquatic organisms), R51 (toxic to aquatic organisms), R52 (harmful to aquatic organisms), R53 (may cause long-term adverse effects in the aquatic environment), R60 (may impair fertility) or R61 (may cause harm to the unborn child), or any combinations of risk phrases containing any of the above risk phrases, as defined in Council Directive 67/548/EEC of 27 June 1967 on the approxima ...[+++]tion of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances(2), and its subsequent amendments.

(27) Concerning the environmental risk assessment for part C, risk management, labelling, monitoring, information to the public and safeguard clause, this Directive should be a point of reference for GMOs as or in products authorised by other Community legislation which should therefore provide for a specific environmental risk assessment, to be carried out in accordance with the principles set out in Annex II and on the basis of information specified in Annex III without prejudice to additional requirements laid down by the Community ...[+++] legislation mentioned above, and for requirements as regards risk management, labelling, monitoring as appropriate, information to the public and safeguard clause at least equivalent to that laid down in this Directive.

Concerning the environmental risk assessment for part C, risk management, labelling, monitoring, information to the public and safeguard clause, this Directive should be a point of reference for GMOs as or in products authorised by other Community legislation which should therefore provide for a specific environmental risk assessment, to be carried out in accordance with the principles set out in Annex II and on the basis of information specified in Annex III without prejudice to additional requirements laid down by the Community legi ...[+++]slation mentioned above, and for requirements as regards risk management, labelling, monitoring as appropriate, information to the public and safeguard clause at least equivalent to that laid down in this Directive.